Introduction
Sepsis is a common condition that varies in severity from uncomplicated sepsis, as might be experienced with mild infections, to severe sepsis, which involves the failure of major organs and can be fatal.
Despite being responsible for 1,400 deaths a day worldwide (Kieft et al 1993) , sepsis has not received the same media attention as heart disease, stroke or cancer. A study carried out in 2001 shows that early aggressive treatment of severe sepsis in A&E before transfer to an intensive care unit (ICU), known as early goal directed therapy (EGDT), can increase survival by 16 per cent (Rivers et al 2001) . Nevertheless, few UK hospitals carry out this treatment.
Although there are standard definitions of sepsis and severe sepsis, many nurses and doctors are unaware of these (Poeze et al 2004) . As a result, some patients with severe sepsis may be misdiagnosed or treated too slowly, and this delay can adversely affect patient outcome (Vincent et al 2002) .
In 2002, an international Surviving Sepsis Campaign was launched by the European Society of Intensive Care Medicine, the International Sepsis Forum and the US Society of Critical Care Medicine, and evidence based guidelines for managing severe sepsis were produced (Dellinger et al 2004) . The main aim of the campaign is to reduce mortality from sepsis by 25 per cent by 2009.
What is sepsis?
In the past, there has been a general lack of consensus about the definition of sepsis, and various terms were used interchangeably, including bacteraemia, septicaemia and sepsis.
In response to this, a group of experts from across the globe produced clear and concise definitions for sepsis, severe sepsis and septic shock, and introduced a new term: systemic inflammatory response syndrome (SIRS) (Bone et al 1992) .
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In this article, the author clarifies the definition of sepsis, severe sepsis and septic shock, describes the physiological changes that occur and the initial treatment used to improve patient outcome, and examines the concept of early goal directed therapy (EGDT).
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Time ouT 1
Before reading the definitions of SIRS and sepsis below, draft your own definition of sepsis.
Imagine you are explaining it to a nursing student. What would you say are the key features of severe sepsis?
A raised blood lactate level is a sign of severe sepsis because physiological changes to the cardiovascular and coagulation systems mean that tissues receive too little oxygen and have to rely on anaerobic metabolism, which produces lactic acid. The process is similar to the development of cramp during exercise, when muscles have to produce energy without oxygen.
Definitions
Although the standard definitions of sepsis, SIRS, severe sepsis and septic shock described below have existed for some time, it seems that many healthcare professionals are still unfamiliar with them. In a recent study (Poeze et al 2004) , 1,058 doctors were interviewed about the definition of sepsis and only 17 per cent agreed on any single definition.
Sepsis
Sepsis is defined as a known or suspected infection accompanied by evidence of SIRS. This includes two or more of the SIRS criteria: n High or low temperature: more than 38ºC or less than 36ºC n Heart rate: more than 90 beats per minute n Respiratory rate: more than 20 breaths per minute or arterial carbon dioxide pressure (PaC0 2 ) of less than 4.2kPa n High or low white blood cell count: more than 12,000 per millilitre or less than 4,000 per millilitre (Bone et al 1992 , Dellinger et al 2004 , Levy et al 2001 . A systemic inflammatory response can be caused by any major insult to the body: burns, acute pancreatitis, myocardial infarction, or trauma, as well as by sepsis. A&E staff must therefore consider if SIRS is caused by an infection or some other insult.
If there are clinical indicators of infection, as well as SIRS, it is reasonable to assume the presentation is sepsis.
Severe sepsis
Severe sepsis is defined as sepsis, as defined above, that is associated with organ dysfunction, hypotension or poor perfusion. All organs, including the cardiovascular system, lungs, liver, kidneys and brain, can be affected. Signs of organ dysfunction are listed in Box 1.
Organ dysfunction can also affect the liver, evidenced by abnormal liver function tests (LFTs), and the gastrointestial tract, evidenced by bowel stasis, or ileus.
Septic Shock
Septic shock is defined as severe sepsis with hypotension that does not respond to adequate fluid resuscitation. In this situation, a patient's systolic blood pressure (BP) can remain less than 90mmHg despite receiving up to two litres of intravenous (IV) fluid (Bone et al 1992 , Dellinger et al 2004 , Levy et al 2001 .
Hypotension is not always a reliable indicator of shock, and some patients can have septic shock with a systolic BP of more than 90mmHg. If a septic patient has a lactate level of more than 4mmol/L and a systolic BP of more than 90mmHg, they are still considered to have septic shock, although this type of shock is said to be 'occult' or 'hidden', and has been referred to as 'cryptic shock' (Vincent et al 2002) .
Physiological changes
The most significant physiological changes in severe sepsis or septic shock are an exaggeration of those produced by the normal immune response to infection or trauma: vasodilation, leaky capillaries and clot formation.
Inflammation is a normal physiological response to a variety of insults, and it is restricted normally to around the site of infection or insult. Severe sepsis, however, produces an exaggerated inflammatory response throughout the body.
Various inflammatory mediators, such as histamine, prostaglandins, cytokines including tumour necrosis factor, and interleukins, are released into the circulation causing widespread vasodilation.
Blood vessels dilate widely causing BP to plummet ( Fig. 1 ) and capillaries become increasingly permeable, which allows fluid to leak out from the circulation. This produces hypovolaemia, which can lower the BP even further.
The coagulation system also becomes activated and small blood clots, or microthrombi, form in the small blood vessels (Fig. 2 ). These interfere with blood flow to Box 1. Signs of organ dysfunction n Hypotension: defined as a systolic blood pressure (BP) of less than 90mmHg, a mean arterial BP of less than 60mmHg, or a reduction in systolic BP of more than 40mmHg from the patient's normal BP without other causes of hypotension
n Altered mental state: should be assessed with the involvement of the patient's family n Hyperglycaemia: in the absence of diabetes n Hypoxaemia: defined as an oxygen saturation (SpO 2 ) of less than 93 per cent or an arterial oxygen pressure (PaO 2 ) of less than 9kPa on an arterial blood gas (ABG) sample n Acute oliguria: defined as a urine output of less than 0.5ml/kg/hr and/or raised blood urea and creatinine continuing professional development the tissues and organs, and this, combined with hypotension and hypovolaemia, can lead to organ failure. Normally, the body will attempt to break down blood clots by fibrinolysis and will release anti-inflammatory mediators to counter the inflammatory mediators (Balk et al 2004) .
But in severe sepsis, fibrinolysis is inhibited by the release of plasminogen activator inhibitor. Furthermore, the inflammatory and pro-coagulation response is persistent, to the extent that the body cannot restore homeostasis.
Initial treatment
The Surviving Sepsis Campaign guidelines for managing severe sepsis (Dellinger et al 2004) state that treatment should begin as soon as diagnosis is made, and should not be delayed until ICU beds are available.
In the same way that treatment during the hour immediately after admission, the 'golden hour', can improve outcomes for patients with trauma or acute myocardial infarction, those with severe sepsis can be helped most in the hours immediately after its onset. Nguyen et al (2000) demonstrate that the care given to critically ill patients in A&E can reverse physiological derangements and help avoid admission to intensive care.
Intensive care unit and high dependency unit (HDU) beds are scarce, and there can be delays in transferring patients, so it is essential that aggressive resuscitation is started while patients are waiting.
The treatment described in Box 2 should be carried out in the first hour after diagnosis of severe sepsis or septic shock.
Time ouT 3
How comfortable are you with this brief summary of the physiological changes associated with sepsis and septic shock? If you are unsure, think of a presenting sign or symptom of sepsis or septic shock and trace it back to the physiological origin using a simple flow chart. Check your understanding with a colleague. Can you use the flow chart for teaching in your department?
Box 2. Treatment during the first hour after diagnosis
n Baseline observation of vital signs should be made, including heart rate, BP, temperature, respiratory rate, SpO 2 and level of consciousness n Blood specimens should be taken for a full blood count (FBC), to measure urea and electrolytes (U&E), glucose and lactate, and for clotting screen, blood culture tests and LFTs
n Arterial blood gas measurement should be made n Blood cultures should be taken before antibiotics are given from a peripheral vein and where possible using IV lines, such as Hickman lines, already in place n Lactate, an important indicator of tissue perfusion, should be measured in suspected severe sepsis, even if no signs of hypotension. Bicarbonate (HCO 3 ) concentration of less than 20mmol/L seen on ABG or U&E result is a warning sign that lactate concentration is high n Intravenous broad spectrum antibiotics should be administered promptly, a course of action that reduces risk of death by between 10 and 15 per cent (Wheeler and Bernard 1999) . In cases of severe sepsis, antibiotics should be given within one hour of diagnosis (Dellinger et al 2004) n Intravenous fluid challenges should be administered if systolic BP is less than 90mmHg, or mean arterial pressure (MAP) less than 65mmHg. A fluid challenge is usually 500ml given over between five and ten minutes (Acute Life Threatening Events Recognition and Treatment 2003). Repeat fluid challenges up to a total of two litres
n If the patient remains hypotensive, insertion of a central venous line and continuation of IV fluid challenges to achieve a central venous pressure (CVP) of bewteen 8 and 12mmHg should be considered. If, after receiving between 1.5 and 2 litres of fluid, the patient remains hypotensive with an MAP of less than 65mmHg, an IV infusion of the vasoconstrictor, noradrenaline, should be administered and an arterial line inserted to monitor BP accurately n A urinary catheter that allows hourly measurements to be made should be inserted, and a urine specimen should be obtained n The source of the sepsis should be found.
Fig. 1. Dilated blood vessels cause a drop in blood pressure

Tunica intima
Tunica adventitia
Tunica media
Early goal directed therapy Patients with severe sepsis develop an imbalance between oxygen delivery and demand that results in global tissue hypoxia. If this is not corrected, the result is multiorgan failure and death. The progression to serious illness occurs in first six hours after the onset of severe sepsis, so treatment to restore oxygen delivery to tissues and organs has most benefit when undertaken early (Rivers et al 2001) .
Early goal directed therapy is a form of aggressive resuscitation designed to improve the delivery of oxygen to the tissues and organs in the 'golden hour'. A randomised controlled trial by Rivers et al (2001) shows that EGDT can have a dramatic effect on the survival of patients with severe sepsis or septic shock admitted to A&E.
This study involved 263 patients with severe sepsis or septic shock admitted to an urban US A&E who, despite fluid resuscitation of up to two litres of fluid over 30 minutes, either remained hypotensive or had blood lactate concentrations of more than 4 mmol/L.
Patients were randomly assigned to receive either six hours of EGDT or six hours of standard care in A&E before their transfer to the ICU.
Treatment received by the two groups of patients in the Rivers et al (2001) study is outlined in Box 3.
The most dramatic result in this study was the significant difference in mortality between the two groups. Patients in the EGDT group showed a 16 per cent reduction, which means that, for about every seven patients treated with EGDT, one life is saved.
Patients in the EGDT group had less organ failure in the ICU, spent less time on mechanical ventilation and had shorter hospital stays. Bennett (2002) argues that the study is of great significance and suggests that 'hypo- 
Time ouT 4
Look back over the initial treatment described in Box 2 and consider what you would tell a student about early treatment goals. For example, how do these measures support organ function?
Fig. 2. Small blood clots, or microthrombi, form in the blood vessels
Microthrombus continuing professional development volaemia is an important and unrecognized problem in septic patients presenting to the emergency room'.
Central venous oxygen saturations
One of the key differences in the EGDT group was the measurement of oxygen saturation of blood in the central veins (ScvO 2 ) by a CVP line (Fig. 3) , which is inserted in the same way as a standard triple lumen central line.
To measure ScvO 2 , the tip of the CVP line sits in the vena cava close to the right atrium, and a sensor at its tip measures the oxygen saturation of blood returning to the heart (Fig. 4) .
The saturation of venous blood in the central veins is normally about 75 per cent and a lesser value can signal that the tissues are using more oxygen than is being delivered, and are hypoxic.
The Rivers et al (2001) study demonstrates a greater survival rate than that reported in studies using other treatments for severe sepsis, such as activated protein C (Bennet 2002). This has profound implications for how we care for patients with severe sepsis.
Barriers to use of EDGT in the UK Early goal directed therapy is based on research carried out in a US emergency room and, at first, it may not appear to be easily transferrable to the UK healthcare system.
One of the most obvious barriers to implementing this system is poor communication between hospital departments. A&E and ICU staff may have poorly established links, and some A&E
Time ouT 5
Read the case study described in Box 4. Now consider your own departmental protocols for early management of sepsis and septic shock and ask what part measuring ScvO 2 plays in this. If it does not feature strongly, what challenges must be overcome when introducing this measurement? You could obtain a copy of the Rivers et al (2001) study to examine and discuss within a local journal club or practice development group staff may feel uneasy about adopting US based research that has been promoted mainly by critical care. Ruffell (2004) suggests other reasons for UK A&E departments failing to adopt EGDT: n no equipment to monitor ScvO 2 n too few medical and nursing staff to facilitate EGDT n too much pressure to discharge patients from A&E within four hours. Kinnear (2004) echoes these suggestions, argues that logistics and resources are the main barriers to implementing EGDT, and points out that, although EGDT is expensive, because of the high price of CVP lines and ScvO2 display machines, it is cost effective when balanced against the likelihood of its use leading to shorter stays for patients in ICUs.
Another potential problem of EGDT is that A&E department staff do not routinely undertake haemodynamic monitoring of arterial and CVP lines, and rarely use noradrenaline or dobutamine.
Critical care outreach teams can support A&E staff who implement EGDT by offering help and education on transducing invasive lines and using inotropes, but few hospitals have full-time outreach services, which means that patients are less likely to receive this treatment in A&E at night or at weekends.
While the UK and US healthcare systems are different, the challenges described above are not unique to the UK. Indeed, Stauss (2005) makes reference to the same problems when describing the introduction of EGDT into a US emergency department.
Early goal directed therapy is a new initiative in the UK and a clearer picture of the barriers to its implementation will emerge as more hospitals adopt it.
Introducing EGDT into the UK As part of a Surviving Sepsis Campaign initiative at Chesterfield Royal Hospital, medical and nursing ICU staff approached their A&E colleagues to make them aware both of EGDT and of recently published, evidence based guidelines on managing severe sepsis.
Copies of the Rivers et al (2001) study were made available and teaching sessions were organised. Senior A&E staff agreed that the potential benefits to patients were significant, a trial introduction of EGDT was planned, and a guideline was written and agreed upon by the emergency care and critical care directorates.
An ScvO 2 monitor was placed temporarily in the A&E department's resuscitation area, and a stock of CVP lines were acquired, with their cost split between emergency and critical care.
Because it was a new therapy, it was agreed that initially it would be carried out only between 9am and 5pm on weekdays, when support from critical care would be available from the consultant anaesthetists from the ICU, the consultant nurse for critical care and the critical care outreach team.
Provision of EGDT started in A&E in October 2004, and in the first eight months two patients had received it. Both had ScvO 2 of more than 70 per cent, so blood transfusion or dobutamine were not required. Two other patients were identified in A&E as eligible for EGDT and were transferred to the ICU or HDU to receive it. Another four may have been eligible for EGDT but were identified out of office hours; they too were transferred, but to other ICUs or HDUs.
Box 4. Case study
Mrs L, 54, has been short of breath for three days and is admitted to A&E with possible pneumonia. Her temperature is 38.2ºC, pulse 132 beats per minute, respiratory rate 28 breaths per minute, and her Sp0 2 is 92 per cent on 40 per cent oxygen. Her BP is 125/68mmHg on admission. A chest X-ray shows shadowing at the right base.
Is Mrs L septic?
Yes. Mrs L has a suspected infection and more than two signs of SIRS, namely high temperature, pulse and respiratory rate, and low Sp0 2 . She has blood cultures taken, is given broad spectrum antibiotics and has blood sent for a lactate level test. Arterial blood gas shows a low HCO 3 concentration of 17mmol/L and a pH of 7.34, indicating metabolic acidosis. The blood lactate concentration is 5.3mmol/L. Mrs L is not hypotensive but her BP begins to drop to 110/63mmHg. The concentration of oxygen being delivered by face mask is increased to 60 per cent because Mrs L's Sp0 2 on 40 per cent oxygen has dropped to 90 per cent.
Does Mrs L have severe sepsis?
Yes. Her BP is normal but her lactate concentration is high, which suggests that insufficient oxygen is being delivered to her tissues. There are also signs that her organs are beginning to fail: decreasing BP and increasing oxygen requirement. The critical care outreach team is contacted and Mrs L is moved into the resuscitation bay for EGDT. She receives fluid challenges to try to maintain a mean diastolic BP of 65mmHg, and a systolic BP of more than 90mmHg. After two litres of fluid challenges, Mrs L's BP remains low at 88/52mmHg. A noradrenaline infusion is started to vasoconstrict the blood vessels and maintain the systolic BP above 90mmHg. A CVP line to measure ScvO 2 is inserted. The ScvO 2 reading is 73 per cent, which is above the 70 per cent goal described in Box 3, and indicates that oxygen delivery to the tissues is adequate, so Mrs L does not require blood or dobutamine. Mrs L is transferred to the ICU.
continuing professional development
After the collaboration between the ICU and A&E at Chesterfield Royal Hospital began, it appears that patients who are identified as severely septic receive more timely and appropriate treatment concerning the measurement of lactate and blood cultures, receiving early antibiotics and prompt fluid resuscitation, although this is only anecdotal evidence based on a few patients.
The challenge now is to collect audit data on how quickly patients receive antibiotics or how much fluid they are given, and whether this affects mortality rates related to severe sepsis or septic shock.
The initiative has, however, raised awareness of the Surviving Sepsis Campaign and has shown that measuring ScvO 2 can be carried out in A&E through collaboration between emergency and critical care staff. A lot of work is still to be done to ensure that every appropriate patient in A&E is considered for this life saving treatment, and we are yet to test the ease with which EGDT is carried out on a patient who has a ScvO 2 of less than 70 per cent and who requires blood transfusion and dobutamine.
Educational sessions will now be provided for staff in the emergency admissions unit so that they can also be involved in identifying patients who meet the criteria for EGDT.
Conclusion
Research showing the effectiveness of EGDT was carried out in 2001, yet few UK A&E department staff members appear to be aware of it.
Establishing the full EGDT protocol, including the monitoring of ScvO 2 , represents a challenge for many A&E departments but even adopting the less technical elements of the protocol, such as measuring lactate, taking blood cultures, and administering early antibiotics and aggressive fluid resuscitation, can have a dramatic effect on survival rates.
The challenge is to make all A&E and emergency care department staff familiar with the Rivers et al (2001) study and the Surviving Sepsis Campaign, and to encourage them to find ways of working with colleagues in critical care to ensure that patients with severe sepsis are offered this life saving therapy.
n For further information on the Surviving Sepsis Campaign and EGDT, access www. survivingsepsis.org
